
Sign up to save your podcasts
Or
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.
4.6
1313 ratings
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.
1,711 Listeners
17 Listeners
32 Listeners
65 Listeners
12 Listeners
69 Listeners
0 Listeners
113 Listeners
43,337 Listeners
12,581 Listeners
277 Listeners
3,310 Listeners
6 Listeners
60 Listeners
3,352 Listeners
169 Listeners
3 Listeners
131 Listeners
12 Listeners